CEO Dr. Jack Regan joined Steve Darling from Proactive Investors to share news the company will be approaching Government and showing the effectiveness and speed of their MiQLab in detecting plague.
LexaGene Talking to Major Players in Plague Detection
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
October 05, 2021 - October 06, 2021
The in-person and virtual event held in New York City attracted more than 550 attendees, including 100 speakers sharing their expertise, insight, and predictions.